Avadel Pharmaceuticals (AVDL) has issued an announcement.
Starting April 15, 2024, Avadel Pharmaceuticals will list its ordinary shares on the Nasdaq, prompting an obligatory swap of American Depositary Shares (ADSs) for ordinary shares. The Bank of New York Mellon, overseeing the ADSs, will end its ADR program by July 15, 2024, or sooner if no ADSs remain. ADS holders can exchange their shares for ordinary shares either automatically through the Direct Registration System or by contacting BNY Mellon or their respective financial intermediary if they hold certificated shares.
Learn more about AVDL stock on TipRanks’ Stock Analysis page.
